- Home
- PRPO vs OMH Comparison
PRPO vs OMH Comparison
Compare PRPO & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- OMH
- Stock Information
- Founded
- PRPO N/A
- OMH 2015
- Country
- PRPO United States
- OMH Singapore
- Employees
- PRPO N/A
- OMH N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- OMH Real Estate
- Sector
- PRPO Industrials
- OMH Finance
- Exchange
- PRPO Nasdaq
- OMH Nasdaq
- Market Cap
- PRPO 30.2M
- OMH 35.8M
- IPO Year
- PRPO N/A
- OMH 2023
- Fundamental
- Price
- PRPO $20.47
- OMH $1.24
- Analyst Decision
- PRPO
- OMH Hold
- Analyst Count
- PRPO 0
- OMH 1
- Target Price
- PRPO N/A
- OMH N/A
- AVG Volume (30 Days)
- PRPO 15.0K
- OMH 43.6K
- Earning Date
- PRPO 11-06-2025
- OMH 10-30-2025
- Dividend Yield
- PRPO N/A
- OMH N/A
- EPS Growth
- PRPO N/A
- OMH N/A
- EPS
- PRPO N/A
- OMH N/A
- Revenue
- PRPO $21,242,000.00
- OMH $7,976,578.00
- Revenue This Year
- PRPO N/A
- OMH $28.40
- Revenue Next Year
- PRPO N/A
- OMH $23.07
- P/E Ratio
- PRPO N/A
- OMH N/A
- Revenue Growth
- PRPO 27.05
- OMH 117.53
- 52 Week Low
- PRPO $3.90
- OMH $0.59
- 52 Week High
- PRPO $22.38
- OMH $5.10
- Technical
- Relative Strength Index (RSI)
- PRPO 57.34
- OMH 57.49
- Support Level
- PRPO $16.40
- OMH $1.17
- Resistance Level
- PRPO $21.67
- OMH $1.29
- Average True Range (ATR)
- PRPO 1.46
- OMH 0.06
- MACD
- PRPO 0.10
- OMH 0.01
- Stochastic Oscillator
- PRPO 75.98
- OMH 81.82
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.